Business Description
Swedish Orphan Biovitrum AB
ISIN : SE0000872095
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.47 | |||||
Debt-to-EBITDA | 2.2 | |||||
Interest Coverage | 2.81 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.41 | |||||
Beneish M-Score | -2.57 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.5 | |||||
3-Year EBITDA Growth Rate | 1.1 | |||||
3-Year EPS without NRI Growth Rate | -2.5 | |||||
3-Year Book Growth Rate | 15.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 40.72 | |||||
Future 3-5Y Total Revenue Growth Rate | 12.56 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.73 | |||||
Quick Ratio | 0.49 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 258.72 | |||||
Days Sales Outstanding | 74.51 | |||||
Days Payable | 63.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.2 | |||||
Shareholder Yield % | -11.53 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 77.19 | |||||
Operating Margin % | 17.71 | |||||
Net Margin % | 9.04 | |||||
FCF Margin % | 21.6 | |||||
ROE % | 6.35 | |||||
ROA % | 2.87 | |||||
ROIC % | 4.37 | |||||
ROC (Joel Greenblatt) % | 958.45 | |||||
ROCE % | 7.07 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 45.96 | |||||
Forward PE Ratio | 26.88 | |||||
PE Ratio without NRI | 40.82 | |||||
Shiller PE Ratio | 37.73 | |||||
Price-to-Owner-Earnings | 23.33 | |||||
PEG Ratio | 5.37 | |||||
PS Ratio | 4.17 | |||||
PB Ratio | 2.72 | |||||
Price-to-Free-Cash-Flow | 19.56 | |||||
Price-to-Operating-Cash-Flow | 14.71 | |||||
EV-to-EBIT | 29.36 | |||||
EV-to-EBITDA | 15.42 | |||||
EV-to-Revenue | 5.06 | |||||
EV-to-FCF | 22.78 | |||||
Price-to-Projected-FCF | 2.16 | |||||
Price-to-DCF (Earnings Based) | 3.31 | |||||
Price-to-DCF (FCF Based) | 1.57 | |||||
Price-to-Median-PS-Value | 0.85 | |||||
Earnings Yield (Greenblatt) % | 3.4 | |||||
FCF Yield % | 4.88 | |||||
Forward Rate of Return (Yacktman) % | 7.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Swedish Orphan Biovitrum AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 39,056.43 | ||
EPS (TTM) (MXN) | 10.377 | ||
Beta | -0.24 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (MXN) | 0 | ||
20-Day SMA (MXN) | 523.55284 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (MXN) | 523.552837 - 523.55284 | ||
Shares Outstanding (Mil) | 342.53 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Swedish Orphan Biovitrum AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Swedish Orphan Biovitrum AB Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Swedish Orphan Biovitrum AB Frequently Asked Questions
What is Swedish Orphan Biovitrum AB(MEX:SOBI)'s stock price today?
When is next earnings date of Swedish Orphan Biovitrum AB(MEX:SOBI)?
Does Swedish Orphan Biovitrum AB(MEX:SOBI) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |